论文部分内容阅读
目的:探讨乳糖酸阿奇霉素治疗小儿支气管炎的临床价值及可行性。方法:随机选取2010年5月一2014年5月在我院接受治疗的小儿支气管炎患儿118例,并根据患儿具体情况分为观察组和对照组各59例,对照组患儿在常规治疗基础上采用红霉素进行治疗,治观察组患儿在常规治疗基础上采用乳糖酸阿奇霉素进行治疗,观察并比较两组的治疗效果。结果:观察组治疗总有效率91.5%,对照组治疗总有效率71.2%,观察组明显高于对照组,P<0.05,有统计学意义;观察组患儿湿罗音消失时间、哮鸣音消失时间、咳嗽消失时间、住院时间均明显短于对照组,P<0.05,有统计学意义。结论:乳糖酸阿奇霉素治疗小儿支气管炎疗效显著,可有效缓解患儿的临床症状。
Objective: To investigate the clinical value and feasibility of azithromycin lactobionate in the treatment of pediatric bronchitis. Methods: A total of 118 cases of children with bronchitis treated in our hospital from May 2010 to May 2014 were randomly selected and divided into observation group (59 cases) and control group (59 cases) according to the specific conditions of children. The control group Treatment based on the use of erythromycin for treatment, treatment observation group of children treated with azithromycin lactobactam on the basis of conventional treatment were observed and compared the therapeutic effect of the two groups. Results: The total effective rate was 91.5% in the observation group and 71.2% in the control group, the observation group was significantly higher than that of the control group, P <0.05, with statistical significance; the disappearance time of wet rales, wheeze Disappear time, cough disappear time, hospitalization time were significantly shorter than the control group, P <0.05, with statistical significance. Conclusion: Azithromycin lactobionate treatment of children with bronchitis significant effect, which can effectively alleviate the clinical symptoms in children.